Porton Pharma Solutions Ltd. (SHE:300363)
20.34
-0.67 (-3.19%)
Mar 19, 2026, 3:04 PM CST
Porton Pharma Solutions Market Cap
Porton Pharma Solutions has a market cap or net worth of 11.35 billion as of March 19, 2026. Its market cap has increased by 23.77% in one year.
Market Cap
11.35B
Enterprise Value
11.90B
Revenue
3.43B
Ranking
n/a
PE Ratio
n/a
Stock Price
20.34
Market Cap Chart
Since January 29, 2014, Porton Pharma Solutions's market cap has increased from 3.94B to 11.35B, an increase of 188.01%. That is a compound annual growth rate of 9.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 11.35B | -9.60% |
| Dec 31, 2025 | 12.55B | 45.94% |
| Dec 31, 2024 | 8.60B | -37.37% |
| Dec 29, 2023 | 13.73B | -38.42% |
| Dec 30, 2022 | 22.31B | -54.20% |
| Dec 31, 2021 | 48.70B | 145.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Henan Lingrui Pharmaceutical | 12.49B |
| Zhejiang Hisun Pharmaceutical | 12.25B |
| Guangdong Taienkang Pharmaceutical | 11.63B |
| Shanghai Yizhong Pharmaceutical | 11.40B |
| Zhejiang Hisoar Pharmaceutical | 11.40B |
| Zhejiang CONBA Pharmaceutical | 11.21B |
| Mayinglong Pharmaceutical Group | 11.20B |
| Beijing Foyou Pharma CO.,LTD | 11.02B |